United Network for Organ Sharing (UNOS) and Walgreens are working together to study issues around transplant outcomes and medication adherence. UNOS researchers along with the Walgreens Center for Health & Wellness Research will assess outcomes of patients who had a kidney, heart or liver transplant and filled transplant-related prescriptions at Walgreens pharmacies.
This joint project marks the first time UNOS has undertaken a scientific collaboration with a national retail pharmacy chain.
“Our goal is to provide valuable insights that the transplant community can use in their everyday practice to benefit patients,” said UNOS Senior Director of Research and Business Development, Ryan Ehrensberger.
Researchers will examine patient characteristics, comorbidities, adherence, and post-transplant outcomes.
“We’re excited to collaborate with UNOS on this research,” said Glen Pietrandoni, Senior Director of Patient Care & Advocacy at Walgreens. “The research will help highlight the role that community pharmacists play in supporting transplant patients throughout their journey.”
The research is already underway after receiving institutional review board approval in January. Researchers plan to begin publishing results later this year.
